Montrusco Bolton Investments Inc. Invests $213.85 Million in Ryan Specialty Holdings Inc. $RYAN

Montrusco Bolton Investments Inc. bought a new position in Ryan Specialty Holdings Inc. (NYSE:RYANFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,212,231 shares of the company’s stock, valued at approximately $213,852,000. Ryan Specialty makes up about 2.4% of Montrusco Bolton Investments Inc.’s holdings, making the stock its 18th largest position. Montrusco Bolton Investments Inc. owned about 1.22% of Ryan Specialty as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Allspring Global Investments Holdings LLC bought a new position in Ryan Specialty during the second quarter valued at approximately $37,321,000. Index Fund Advisors Inc. purchased a new stake in Ryan Specialty during the second quarter valued at approximately $1,037,000. Vanguard Personalized Indexing Management LLC increased its holdings in Ryan Specialty by 6.1% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 9,478 shares of the company’s stock valued at $644,000 after buying an additional 546 shares during the last quarter. Callan Family Office LLC purchased a new stake in Ryan Specialty during the second quarter valued at approximately $740,000. Finally, Blair William & Co. IL increased its holdings in Ryan Specialty by 1.1% during the second quarter. Blair William & Co. IL now owns 2,814,195 shares of the company’s stock valued at $191,337,000 after buying an additional 29,279 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Chairman Patrick G. Ryan acquired 276,634 shares of the company’s stock in a transaction on Friday, September 12th. The stock was acquired at an average cost of $51.84 per share, with a total value of $14,340,706.56. Following the purchase, the chairman directly owned 13,699,959 shares of the company’s stock, valued at approximately $710,205,874.56. This represents a 2.06% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 52.21% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on RYAN shares. Citigroup started coverage on shares of Ryan Specialty in a research note on Wednesday, August 13th. They issued a “buy” rating and a $74.00 price objective for the company. UBS Group reduced their price objective on shares of Ryan Specialty from $80.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday. Wolfe Research raised shares of Ryan Specialty to a “strong-buy” rating in a research note on Tuesday, September 16th. Wells Fargo & Company increased their price objective on shares of Ryan Specialty from $60.00 to $64.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Ryan Specialty in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $71.08.

Check Out Our Latest Research Report on RYAN

Ryan Specialty Price Performance

Shares of NYSE:RYAN opened at $55.18 on Monday. The company has a debt-to-equity ratio of 2.88, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a fifty day moving average price of $56.28 and a 200 day moving average price of $63.91. Ryan Specialty Holdings Inc. has a fifty-two week low of $50.08 and a fifty-two week high of $77.16. The firm has a market cap of $14.55 billion, a price-to-earnings ratio of 157.66, a P/E/G ratio of 1.54 and a beta of 0.63.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.66. Ryan Specialty had a net margin of 6.81% and a return on equity of 48.70%. The firm had revenue of $855.17 million during the quarter, compared to analyst estimates of $837.52 million. During the same quarter in the prior year, the business earned $0.58 earnings per share. Ryan Specialty’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, sell-side analysts expect that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Tuesday, August 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 137.14%.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.